ArticleTranslational lung cancer research2025

Real-world efficacy of immune checkpoint inhibitors in PD-L1 negative non-small cell lung cancer: a multicenter retrospective study.

Suguru Muraoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.